Rossari Biotech Ltd
ROSSARIRossari Biotech Ltd
ROSSARI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 32.62 | 4.32 | 0.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 30.76 | 3.47 | 1.33% |
Forecast & Ratings
Detailed Forecast from 4 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Rossari Biotech is engaged in business of textile and specialty chemical manufacturing.
Investor Presentation
View olderPeers
Compare with peersGujarat Fluorochemicals Ltd
Vinati Organics Ltd
Akzo Nobel India Ltd
Navin Fluorine International Ltd
Aarti Industries Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 517.13 | 603.81 | 718.47 | 1,496.51 | 1,662.32 | 1,838.18 | 1,930.75 | |||||||
Raw Materials | 355.23 | 369.26 | 470.62 | 1,128.08 | 1,183.96 | 1,357.04 | 1,666.39 | |||||||
| Power & Fuel Cost | 1.26 | 1.74 | 2.40 | 11.92 | 20.40 | 23.30 | ||||||||
| Employee Cost | 27.52 | 37.21 | 41.98 | 67.93 | 98.62 | 103.13 | ||||||||
| Selling & Administrative Expenses | 38.07 | 50.79 | 36.70 | 37.93 | 58.89 | 61.54 | ||||||||
| Operating & Other expenses | 16.59 | 36.57 | 34.11 | 53.67 | 71.00 | 35.79 | ||||||||
EBITDA | 78.46 | 108.24 | 132.66 | 196.98 | 229.45 | 257.38 | 264.36 | |||||||
| Depreciation/Amortization | 12.19 | 16.85 | 22.83 | 48.06 | 62.93 | 60.39 | 61.69 | |||||||
| PBIT | 66.27 | 91.39 | 109.83 | 148.92 | 166.52 | 196.99 | 202.67 | |||||||
| Interest & Other Items | 2.88 | 3.56 | 2.99 | 12.66 | 22.32 | 19.37 | 14.21 | |||||||
| PBT | 63.39 | 87.83 | 106.84 | 136.26 | 144.20 | 177.62 | 188.46 | |||||||
| Taxes & Other Items | 17.71 | 22.58 | 26.62 | 38.60 | 36.96 | 46.93 | 49.70 | |||||||
| Net Income | 45.68 | 65.25 | 80.22 | 97.66 | 107.24 | 130.69 | 138.76 | |||||||
| EPS | 9.44 | 13.16 | 15.62 | 18.26 | 19.46 | 23.68 | 25.12 | |||||||
| DPS | 0.00 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | |||||||
| Payout ratio | 0.00 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
Company Updates
Peers & Comparison
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Rossari Biotech Ltd | 34.64 | 4.32 | 0.06% |
| Gujarat Fluorochemicals Ltd | 105.21 | 7.71 | 0.07% |
| Vinati Organics Ltd | 61.39 | 8.06 | 0.37% |
| Akzo Nobel India Ltd | 43.68 | 14.01 | 1.59% |
Price Comparison
Compare ROSSARI with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Rossari Biotech Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
SBI Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 4.0768% | Percentage of the fund’s portfolio invested in the stock 0.54% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/63 (-4) |
Motilal Oswal Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.7145% | Percentage of the fund’s portfolio invested in the stock 2.99% | Change in the portfolio weight of the stock over the last 3 months 0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/47 (+7) |
UTI Small Cap Fund - Direct Growth Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8886% | Percentage of the fund’s portfolio invested in the stock 0.88% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 59/99 (+11) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
ROSSARI has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.61 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 16, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateMay 24, 2023
Dividend/Share
₹0.50
Ex DateEx Date
May 24, 2023
Cash Dividend
Ex DateEx DateJul 7, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Jul 7, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 8, 2021
Rossari Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 November 2024 .Powered by Capital Market - Live
Net profit of Rossari Biotech rose 7.22% to Rs 35.33 crore in the quarter ended September 2024 as against Rs 32.95 crore during the previous quarter ended September 2023. Sales rose 3.08% to Rs 498.35 crore in the quarter ended September 2024 as against Rs 483.47 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales498.35483.47 3 OPM %13.2313.15 - PBDT63.2759.92 6 PBT48.1144.81 7 NP35.3332.95 7 Powered by Capital Market - Live
Rossari Biotech will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
Glenmark Life Sciences Ltd leads gainers in ‘A’ group
Rossari Biotech Q1 Results Review - Steady Performance: ICICI Securities
Add Rossari Biotech, target price Rs 885: ICICI Securities
Rossari Biotech announced that the 15th Annual General Meeting (AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live
Rossari Biotech consolidated net profit rises 19.44% in the June 2024 quarter
Accumulate Rossari Biotech; target of Rs 843: KR Choksey
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 28.87%, vs industry avg of 6.09%
Increasing Market Share
Over the last 5 years, market share increased from 0.93% to 2.19%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 23.4%, vs industry avg of -1.55%